• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在原位肝移植再灌注损伤中,血小板的激活和单核细胞组织因子表达增加。

Platelet activation and increased tissue factor expression on monocytes in reperfusion injury following orthotopic liver transplantation.

机构信息

General Surgery, Heinrich Heine University Duesseldorf, Duesseldorf, Germany.

出版信息

Platelets. 2010;21(5):348-59. doi: 10.3109/09537101003739897.

DOI:10.3109/09537101003739897
PMID:20569187
Abstract

Platelets have been implicated in the pathogenesis of liver damage after orthotopic liver transplantation (OLT). Early graft dysfunction is frequently caused by reperfusion injury subsequent to cold ischemia (IRI). Therefore, we investigated activation of the pivotal haemostatic cells, platelets and monocytes, from patients with elevated markers of IRI and from patients with uneventful course (control-group), respectively during the first week after OLT. Flow cytometry analysis of citrate anticoagulated blood samples revealed that platelets from IRI patients became significantly activated within 48 h after OLT in vivo, with increased surface presentation of P-selectin, CD40L, thrombospondin-1 and tissue-factor. Platelet activation in IRI patients on post-transplant day 2 was accompanied by significantly enhanced tissue-factor expression on peripheral blood monocytes, significant elevated levels of C-reactive protein and hepatocellular damage. Towards post-transplant day 4, levels of platelet-derived microparticles rose significantly in IRI patients if contrasted to control patients. Thus, activated cellular haemostasis is involved in the early inflammatory response of hepatocellular damage subsequent to reperfusion of the transplanted liver. Targeting distinct activation patterns of platelets and monocytes in an early phase of hepatic grafting may counteract the extent of IRI via inhibition of micro-thrombus formation and inflammation without exacerbating the existing bleeding risk.

摘要

血小板在原位肝移植(OLT)后肝损伤的发病机制中起作用。早期移植物功能障碍通常是由冷缺血(IRI)后继发的再灌注损伤引起的。因此,我们分别在 OLT 后第一周内,研究了来自 IRI 标志物升高患者和无并发症患者(对照组)的关键止血细胞血小板和单核细胞的激活情况。用柠檬酸盐抗凝的血液样本进行流式细胞术分析显示,IRI 患者的血小板在 OLT 后体内 48 小时内明显激活,表面 P-选择素、CD40L、血小板反应蛋白-1 和组织因子的表达增加。在移植后第 2 天,IRI 患者的血小板激活伴随着外周血单核细胞中组织因子表达的显著增强、C 反应蛋白水平的显著升高和肝细胞损伤。到移植后第 4 天,如果与对照组相比,IRI 患者的血小板衍生微粒水平显著升高。因此,激活的细胞止血在再灌注后的肝细胞损伤的早期炎症反应中起作用。在肝移植的早期阶段针对血小板和单核细胞的不同激活模式进行靶向治疗,可能通过抑制微血栓形成和炎症而不会加重现有出血风险,从而减轻 IRI 的程度。

相似文献

1
Platelet activation and increased tissue factor expression on monocytes in reperfusion injury following orthotopic liver transplantation.在原位肝移植再灌注损伤中,血小板的激活和单核细胞组织因子表达增加。
Platelets. 2010;21(5):348-59. doi: 10.3109/09537101003739897.
2
Platelet P-selectin and GPIIb/IIIa expression after liver transplantation and resection.肝移植和肝切除术后血小板P-选择素及糖蛋白IIb/IIIa的表达
Transpl Int. 2004 Sep;17(8):442-8. doi: 10.1007/s00147-004-0747-y. Epub 2004 Aug 17.
3
ADP-dependent platelet function prior to and in the early course of pediatric liver transplantation and persisting thrombocytopenia are positively correlated with ischemia/reperfusion injury.ADP 依赖性血小板功能在儿科肝移植前和早期以及持续血小板减少症与缺血/再灌注损伤呈正相关。
Transpl Int. 2010 Jul;23(7):745-52. doi: 10.1111/j.1432-2277.2010.01054.x. Epub 2010 Feb 3.
4
Recipient levels and function of von Willebrand factor prior to liver transplantation and its consumption in the course of grafting correlate with hepatocellular damage and outcome.肝移植前血管性血友病因子的受体水平和功能及其在移植过程中的消耗与肝细胞损伤和预后相关。
Transpl Int. 2005 Nov;18(11):1258-65. doi: 10.1111/j.1432-2277.2005.00110.x.
5
Increase in expression of monocytic tissue factor (CD142) with monocytes and blood platelet activation in liver cirrhosis.肝硬化时单核细胞组织因子(CD142)表达随单核细胞和血小板激活而增加。
Blood Coagul Fibrinolysis. 2007 Dec;18(8):739-44. doi: 10.1097/MBC.0b013e3282ef99f6.
6
Dependence of platelet function on underlying liver disease in orthotopic liver transplantation.原位肝移植中血小板功能对潜在肝脏疾病的依赖性。
Thromb Res. 2009 Sep;124(4):433-8. doi: 10.1016/j.thromres.2009.06.011. Epub 2009 Jul 18.
7
Phosphodiesterase 3 inhibition reduces platelet activation and monocyte tissue factor expression in knee arthroplasty patients.磷酸二酯酶3抑制可降低膝关节置换术患者的血小板活化和单核细胞组织因子表达。
Anesthesiology. 2009 Dec;111(6):1227-37. doi: 10.1097/ALN.0b013e3181c155ce.
8
Activated monocytes capture platelets for heterotypic association in patients with severe carotid artery stenosis.活化的单核细胞捕获血小板以形成异质复合物,这在严重颈动脉狭窄患者中较为常见。
Thromb Haemost. 2010 Jun;103(6):1193-202. doi: 10.1160/TH09-09-0620. Epub 2010 Mar 29.
9
Wide gene expression profiling of ischemia-reperfusion injury in human liver transplantation.人类肝移植中缺血再灌注损伤的广泛基因表达谱分析。
Liver Transpl. 2007 Jan;13(1):99-113. doi: 10.1002/lt.20960.
10
No evidence for systemic platelet activation during or after orthotopic liver transplantation.原位肝移植期间或之后无全身血小板激活的证据。
Liver Transpl. 2009 Aug;15(8):956-62. doi: 10.1002/lt.21776.

引用本文的文献

1
Viscoelastic Management of Coagulopathy during the Perioperative Period of Liver Transplantation.肝移植围手术期凝血功能障碍的黏弹性管理。
Semin Thromb Hemost. 2023 Mar;49(2):119-133. doi: 10.1055/s-0042-1758058. Epub 2022 Nov 1.
2
miRNA Involvement in Cerebral Ischemia-Reperfusion Injury.微小RNA参与脑缺血再灌注损伤
Front Neurosci. 2022 Jun 10;16:901360. doi: 10.3389/fnins.2022.901360. eCollection 2022.
3
Platelets Boost Recruitment of CD133 Bone Marrow Stem Cells to Endothelium and the Rodent Liver-The Role of P-Selectin/PSGL-1 Interactions.
血小板促进 CD133 骨髓干细胞向血管内皮和啮齿动物肝脏的募集——P-选择素/PSGL-1 相互作用的作用。
Int J Mol Sci. 2020 Sep 3;21(17):6431. doi: 10.3390/ijms21176431.
4
Impact of Different Clinical Perfusates During Normothermic Ex Situ Liver Perfusion on Pig Liver Transplant Outcomes in a DCD Model.常温体外肝脏灌注期间不同临床灌注液对心脏死亡供体模型中猪肝移植结局的影响
Transplant Direct. 2019 Mar 4;5(4):e437. doi: 10.1097/TXD.0000000000000876. eCollection 2019 Apr.
5
Identifying independent risk factors for graft loss after primary liver transplantation.确定初次肝移植后移植物丢失的独立危险因素。
Langenbecks Arch Surg. 2017 Aug;402(5):757-766. doi: 10.1007/s00423-017-1594-5. Epub 2017 Jun 1.
6
Thromboelastographic Evaluation of Coagulation in Patients With Liver Disease.肝病患者凝血功能的血栓弹力图评估
Ann Lab Med. 2017 May;37(3):204-212. doi: 10.3343/alm.2017.37.3.204.
7
Ischemia/Reperfusion.缺血/再灌注
Compr Physiol. 2016 Dec 6;7(1):113-170. doi: 10.1002/cphy.c160006.
8
Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597).微粒介导肝脏缺血再灌注损伤,且是Diannexin(ASP8597)的作用靶点。
PLoS One. 2014 Sep 15;9(9):e104376. doi: 10.1371/journal.pone.0104376. eCollection 2014.
9
Tumor Necrosis Factor-α: Life and Death of Hepatocytes During Liver Ischemia/Reperfusion Injury.肿瘤坏死因子-α:肝脏缺血/再灌注损伤期间肝细胞的生死
Ochsner J. 2013 Spring;13(1):119-30.
10
Cell biology of ischemia/reperfusion injury.缺血/再灌注损伤的细胞生物学。
Int Rev Cell Mol Biol. 2012;298:229-317. doi: 10.1016/B978-0-12-394309-5.00006-7.